prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |review
An important clinical consideration is the generalizability of these data, particularly to women. In the Women's Health Study, a prospective cohort of some 38,000 middle-aged, predominantly postmenopausal American women who were free of cardiovascular disease at study entry, the relative risk of future vascular events increased as the level of C-reactive protein went from low-normal to high-normal. This was true for all vascular events as well as for the specific combined endpoint of MI or stroke.

Reference:
Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
WebsiteRidker PM et al. Circulation 1998;98:731-733.